ArticlePloS one2015

MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma.

Sameer A Dhayat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.